Effect of interferon-alpha on immunoglobulin production by peripheral blood mononuclear cells in multiple myeloma

被引:0
|
作者
Saily, M
Koistinen, P
Laine, S
Soppi, E
Savolainen, ER
机构
[1] UNIV OULU,DEPT CLIN CHEM,FIN-90220 OULU,FINLAND
[2] UNIV OULU,DEPT INTERNAL MED,FIN-90220 OULU,FINLAND
[3] TAMPERE UNIV,DEPT CLIN MICROBIOL,DIV CLIN IMMUNOL,FIN-33101 TAMPERE,FINLAND
关键词
multiple myeloma; immunoglobulin production; interferon-alpha;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To test a hypothesis that interferon-a (IFN) treatment might restore normal immunoglobulin (Ig) production in multiple myeloma (MM), the effect of IFN on Ig isotype (IgG and IgA) production by peripheral blood (PB) and bone marrow (BM) mononuclear cells (MNCs) in MM patients was analyzed by ELISA. IFN at a concentration of 1000 U/ml was found to enhance IgA production by PB MNCs in IgA-MM and had a trend to stimulate IgG production in IgG-MM. The effect of IFN on nonparaprotein Ig isotype production was more variable, with mostly neutral or inhibitory effects being seen in both the MM subtypes. In contrast to the influences observed in MM patients, IFN at the same concentration inhibited both IgG and IgA production by PB MNCs in healthy controls In studying BM cells, IFN was found to reduce IgA production in IgA-MM, but had a neutral effect on IgG production in IgG-MM. In the controls the production of both the IgG and the IgA isotypes by BM MNCs was decreased by IFN. On the basis of these results it seems that the disease itself somehow affects the Ig-producing cells in MM, when measured as different responses of the cells to exogenous IFN in vitro. The results do not support the hypothesis that IFN treatment could restore normal Ig production in MM patients.
引用
收藏
页码:171 / 177
页数:7
相关论文
共 50 条
  • [21] COMBINATION THERAPY OF M2-PROTOCOL AND INTERFERON-ALPHA AS REMISSION INDUCTION IN REFRACTORY MULTIPLE-MYELOMA
    SHIMAMOTO, Y
    MATSUZAKI, M
    ONO, K
    SANO, M
    YAMAGUCHI, M
    HAEMATOLOGIA, 1991, 24 (01) : 9 - 11
  • [22] Deep Sequencing Reveals Myeloma Cells in Peripheral Blood in Majority of Multiple Myeloma Patients
    Vij, Ravi
    Mazumder, Amitabha
    Klinger, Mark
    O'Dea, Denise
    Paasch, Jacob
    Martin, Thomas
    Weng, Li
    Park, Jeesun
    Fiala, Mark
    Faham, Malek
    Wolf, Jeffrey
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2014, 14 (02) : 131 - 139
  • [23] Pamidronate increases markers of bone formation in patients with multiple myeloma in plateau phase under interferon-alpha treatment
    E. Terpos
    J. Palermos
    N. Viniou
    G. Vaiopoulos
    J. Meletis
    X. Yataganas
    Calcified Tissue International, 2001, 68 : 285 - 290
  • [24] Interferon-alpha therapy for multiple hemangiomas associated with coarctation of the aorta
    Hijii, T
    Fukushige, J
    Tasaki, K
    Ueda, K
    HEART AND VESSELS, 1996, 11 (04) : 211 - 214
  • [25] Administration of Interferon-Alpha in Mice Provokes Peripheral and Central Modulation of Immune Cells, Accompanied by Behavioral Effects
    Orsal, Arif S.
    Blois, Sandra M.
    Bermpohl, Daniela
    Schaefer, Martin
    Coquery, Nicolas
    NEUROPSYCHOBIOLOGY, 2008, 58 (3-4) : 211 - 222
  • [26] INHIBITION OF PROTEIN-KINASE-C IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS OF PATIENTS WITH SYSTEMIC LUPUS-ERYTHEMATOSUS - EFFECT ON SPONTANEOUS IMMUNOGLOBULIN PRODUCTION
    CHONG, P
    MATZNER, WL
    YAMIGUCHI, D
    WALLACE, D
    KLINENBERG, JR
    JORDAN, SC
    AUTOIMMUNITY, 1991, 10 (03) : 227 - 231
  • [27] Effect of Co-administration of Tacrolimus on the Pharmacokinetics of Multiple Subcutaneous Administered Interferon-Alpha in Rats
    Yamazaki, Hiroyuki
    Miyake, Masateru
    Nishibayashi, Toru
    Mukai, Tadashi
    Odomi, Masaaki
    Ishida, Tatsuhiro
    Kiwada, Hiroshi
    PHARMACEUTICAL RESEARCH, 2009, 26 (08) : 1832 - 1837
  • [28] Effect of Co-administration of Tacrolimus on the Pharmacokinetics of Multiple Subcutaneous Administered Interferon-Alpha in Rats
    Hiroyuki Yamazaki
    Masateru Miyake
    Toru Nishibayashi
    Tadashi Mukai
    Masaaki Odomi
    Tatsuhiro Ishida
    Hiroshi Kiwada
    Pharmaceutical Research, 2009, 26 : 1832 - 1837
  • [29] Statin use and peripheral blood progenitor cells mobilization in patients with multiple myeloma
    A. Stravodimou
    I. A. Voutsadakis
    Clinical and Translational Oncology, 2014, 16 : 85 - 90
  • [30] Characterization of γδ regulatory T cells from peripheral blood in patients with multiple myeloma
    Ma, Yongyong
    Lei, Huyi
    Tan, Jie
    Xuan, Li
    Wu, Xiuli
    Liu, Qifa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 480 (04) : 594 - 601